T2 BIOSYSTEMS INC (TTOO)
US89853L3024 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -42.95M | -50.08M | -62.00M | -49.24M | -46.80M | |||
| Depreciation Amortization | 259.00K | 859.00K | 1.05M | 1.27M | 1.71M | |||
| Change In Working Capital | 2.45M | -4.04M | -500.00K | -2.17M | -6.54M | |||
| Interest Paid | 2.07M | 3.86M | 3.92M | 3.81M | 3.69M | |||
| Other non cash items | 3.65M | 5.12M | 10.83M | 11.27M | 8.41M | |||
| OPERATING CASH FLOW | -36.59M | -48.14M | -50.63M | -38.87M | -43.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -192.00K | -340.00K | -460.00K | -800.00K | |||
| Other Investing Activity | N/A | 0.00 | 10.00M | 25.25M | -35.46M | |||
| INVESTING CASH FLOW | N/A | -192.00K | 9.66M | 24.79M | -36.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 14.38M | 52.75M | 29.30M | 20.54M | 300.00K | |||
| Other Financing Activity | -1.00K | -62.00K | -240.00K | N/A | 85.31M | |||
| FINANCING CASH FLOW | 14.38M | 52.69M | 29.05M | 20.54M | 85.61M | |||
| CHANGE IN CASH | -22.24M | 4.36M | -11.92M | 6.46M | 6.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.59M | -48.14M | -50.63M | -38.87M | -43.22M | |||
| Capital Expenditure | N/A | -192.00K | -340.00K | -460.00K | -800.00K | |||
| FREE CASH FLOW | -36.62M | -48.33M | -50.97M | -39.33M | -44.02M | |||
All data in USD